算是丑闻吗？

NewFuture

记得以前韩国也发生过造假事件。
还闹得蛮大事的。。。


http://www.straitstimes.com/sing ... 8631543#xtor=CS1-10

3 Singapore-based scientists linked to research fraud


(From left) Prof Kambadur, Dr Sharma and Dr Lokireddy. PHOTOS: CHEW SENG KIM, HARVARD.EDU, PHARMA NUTRITION

NTU professor's posts terminated; another don no longer with NUS; ex-NTU researcher's PhD revoked

Their research was hailed as a breakthrough in the fight against killers such as obesity and diabetes.

But now, at least three scientists working in top Singapore institutions and funded by major government organisations have been linked to scientific fraud in what could emerge as one of the biggest such cases here.

So far, two of the researchers have left their posts and another has had his PhD revoked, and six of their papers have been retracted.

The trio at the centre of the scandal are Professor Ravi Kambadur, 54, who was with the Nanyang Technological University (NTU); Dr Mridula Sharma, who was associate professor at the National University of Singapore's (NUS) Yong Loo Lin School of Medicine; and former NTU researcher Sudarsanareddy Lokireddy.

Their work focused on myostatin - a protein that regulates muscle growth in humans and animals, whose suppression the researchers claimed could keep people in "fat-burning mode" and let them shed kilos.

It was led by Prof Kambadur, whose joint appointments at NTU's School of Biological Sciences and the Singapore Institute for Clinical Sciences - which comes under the Agency for Science, Technology and Research (A*Star) - have been "terminated", according to NTU.

Falsified lab data casts doubt over 'fat-busting discovery' by ex-NTU professor's team
Former Nanyang Technological University (NTU) professor Ravi Kambadur was set to make waves in the world of biomedical research, as the leader of one of four teams awarded up to $10 million each in research grants in 2009.

The proposal that won the grant for the India-trained New Zealander was selected from among 48 contenders, and looked to reprogramme skin cells to change into muscle cells to help slow loss of muscle mass in the elderly. In 2012, his team reported a discovery that could help achieve this goal.

They had found that, by blocking the protein myostatin, muscle growth could be enhanced and fat utilisation in the body could be increased.

The researchers also said this could reduce obesity without the need for strenuous physical activity, and indirectly protect against type-2 diabetes, of which obesity is a main cause.

This research is now being called into question after investigations by NTU revealed that data from laboratory experiments had been falsified.

Lin Yangchen

Dr Sharma is no longer at NUS and Dr Lokireddy has had his PhD from NTU revoked.

NTU, which did not elaborate on how the falsifications were uncovered, said its investigations in December last year led to three myostatin papers published in 2011 and 2012 being retracted. Two other papers were corrected and another withdrawn prior to publication.

Three more papers published from 2012 to 2014, based on research funded by A*Star and the National Research Foundation (NRF), are now being retracted from the journals Molecular Endocrinology and Journal of Biological Chemistry.

Both funding bodies could not confirm how much money had been pumped into the research.

Said NRF chief executive Low Teck Seng: "NRF holds a very high expectation with regard to the research that we fund. We do not condone any fraud or flouting of ethics. In my view, the organisations involved acted swiftly and appropriately."

Scientific misconduct is taken very seriously as false information can have a knock-on effect. In the current case, the retracted papers have already been cited by other researchers in their studies.

NTU said it was obliged to urgently correct the literature as part of its responsibility to the community.

An NUS spokesman confirmed that Dr Sharma is no longer with the university, but declined to comment further.

NewFuture

Retraction Watch, a website that monitors retractions of scientific publications, reported that the falsifications also happened in Dr Lokireddy's NTU doctoral thesis. He got his PhD four years ago.

Since then, he has been a post-doctoral fellow at Harvard Medical School, in the United States, where he published at least one paper as first author, in the prestigious US journal Proceedings Of The National Academy Of Sciences (PNAS) late last year.

A Harvard University spokesman did not respond to questions about Dr Lokireddy's employment status or the integrity of the PNAS paper, but said: "We are fully committed to upholding the highest standards of ethics and to rigorously maintaining the integrity of our research. Any concerns brought to our attention are thoroughly reviewed."

NTU said that "disciplinary proceedings" are being taken against other researchers, and that Prof Kambadur's research students will be re-assigned to appropriate supervisors.

When contacted by The Straits Times, Prof Kambadur declined to comment, saying that he would leave it to NTU to investigate. Dr Sharma and Dr Lokireddy could not be reached for comment.

NewFuture

会不会影响国誉？
听闻他们都素FT来滴。。。
应该素来自未来强国滴。。。

NewFuture

http://www.channel8news.sg/news8 ... html?cid=ch8news-fb

南大教授伪造研究论文资料 被大学解雇

南洋理工大学一名教授，因研究论文的资料造假被解雇，论文也因此被撤回。

据《今日报》的报道，涉及伪造资料的是拉维∙干巴杜尔教授（Prof Ravi Kambadur），他带领一组来自其他机构的研究人员，针对肌肉生长抑制素（Myostatin），也就是人体内产生的蛋白质，进行研究。

研究团队曾撤回或修正六份相关的研究论文。约七个月后，南洋理工大学发现该团队也在另外三份研究论文中伪造资料，并将这些研究论文从两份科学期刊撤回。

南洋理工大学已解雇干巴杜尔教授，并针对其他涉及造假的研究人员采取纪律处分。

南洋理工大学星期三（13日）表示，“他（指干巴杜尔教授）对于（研究）团队的方向，被发现故意疏忽。”

伪造资料的消息是在去年12月传开，南大针对一组来自南大、新加坡国立大学和新加坡科技研究局（A*Star）的研究人员被指研究失误，而展开调查。

调查发现，研究团队多次修改资料，并且没有适当地解释数据是如何得出。调查结果出炉后，一名负责编写被撤回的论文的研究人员Sudarsanareddy Lokireddy的博士学位，被南大撤销。

另外，南大也针对在2012年至2014年间刊登的两份科学期刊《分子内分泌学Molecular Endocrinology》和《生物化学杂志Journal of Biological Chemistry》中的三份研究论文指出，“根据进一步的调查，一些在体外实验研究的资料造假，致使报告结果无效。”

造假的九份研究报告中，就发现干巴杜尔教授和他的妻子Mridula Sharma的名字。Mridula Sharma之前在新加坡国立大学杨璐琳医药学院（NUS Yong Loo Lin School of Medicine）担任副教授一职。

国大在回复媒体询问时证实，Mridula Sharma已不是该大学的职员。

除了这对夫妻的名字，其他参与编写这三份研究论文的还包括Sabeera Bonala、Craig McFarlane 和Lokireddy。

根据新加坡科技研究局的网站，McFarlane目前是新加坡临床科学研究所的首席研究员，而Bonala则经营自己的创业公司。

南大科研诚信官Tony Mayer回应说，南大在研究方面，坚持最高的标准和国际最佳的做法。他说：“南大对科研不端行为保持零容忍的态度，一旦发现有人缺乏科研诚信，校方会毫不犹豫地采取纪律处分。”

他也指出，校方严厉看待科研不端行为的指控，并会调查所有的指控。他表示：“所有博士生、博士毕业生、研究生和项目官员都必须接受科研诚信的网上训练。”

新加坡科技研究局拒绝回应，仅表示调查是由南大带领的。
- CH8/YJ

蛇仔明

硬度人的吹牛功力也会有破功的时候...

NewFuture

蛇仔明 发表于 16-7-2016 07:41 PM
硬度人的吹牛功力也会有破功的时候...

偶领教过他们的功力了。。。

蛇仔明

NewFuture 发表于 16-7-2016 07:54 PM
偶领教过他们的功力了。。。

每次开会一旦有硬度人PRESENT，林北就会头痛。

他可以跟你说一个小时，不过你不知道他在说什么。

然后林北要他说出他的CONTRIBUTION，他就把刚才的故事重头说一遍...

ohia2016

蛇仔明 发表于 16-7-2016 07:41 PM
硬度人的吹牛功力也会有破功的时候...

没有礼貌，牛是神圣的，怎可以吹？
厉害的。。。是你的陆妹吧

jellyfish_8

蛇仔明 发表于 16-7-2016 08:36 PM
每次开会一旦有硬度人PRESENT，林北就会头痛。

他可以跟你说一个小时，不过你不知道他在说什么。

然后林北要他说出他的CONTRIBUTION，他就把刚才的故事重头说一遍...

听的要有定力。
阿三的吹工就像靡靡之音，除了带你游花园，还会让你忘记自己问的东西。。

aquamax

蛇仔明 发表于 16-7-2016 08:36 PM
每次开会一旦有硬度人PRESENT，林北就会头痛。

他可以跟你说一个小时，不过你不知道他在说什么。

然后林北要他说出他的CONTRIBUTION，他就把刚才的故事重头说一遍...

你应该问他等下吃什么。。。